Brian A. Markison

Chief Executive Officer, KING PHARMACEUTICALS INC.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Mar 5, 2025Granted 70,909 shares of Lantheus Holdings, Inc.⁶
Mar 3, 2025Shares withheld for tax 8,637 shares at $94.86 of Lantheus Holdings, Inc.⁸
Dec 19, 2024Shares withheld for tax 15,446 shares at $91.15 of Lantheus Holdings, Inc.⁹
Dec 19, 2024Exercised options 16,666 shares at $6.00 of Lantheus Holdings, Inc.⁹
Dec 19, 2024Exercised options 16,102 shares at $12.42 of Lantheus Holdings, Inc.⁹
Mar 1, 2024Granted 131,496 shares of Lantheus Holdings, Inc.¹⁰
May 11, 2023Granted 2,012 shares of Lantheus Holdings, Inc.¹¹
Mar 27, 2023Sold 13,290 shares at $81.13 of Lantheus Holdings, Inc.¹²
Sep 8, 2022Sold 13,788 shares at $84.84 of Lantheus Holdings, Inc.¹³
Sep 8, 2022Sold 23,852 shares at $84.10 of Lantheus Holdings, Inc.¹³
Sep 8, 2022Sold 4,172 shares at $83.05 of Lantheus Holdings, Inc.¹³
Sep 8, 2022Exercised options 11,725 shares at $17.06 of Lantheus Holdings, Inc.¹³
Sep 8, 2022Exercised options 9,464 shares at $19.11 of Lantheus Holdings, Inc.¹³
Sep 8, 2022Exercised options 3,263 shares at $21.13 of Lantheus Holdings, Inc.¹³
Sep 6, 2022Sold 1,693 shares at $78.50 of Lantheus Holdings, Inc.¹⁴
Sep 6, 2022Exercised options 1,693 shares at $19.78 of Lantheus Holdings, Inc.¹⁴
Aug 8, 2022Bought 850,000 shares at $1.55 of RVL Pharmaceuticals plc⁷
May 6, 2022Granted 2,180 shares of Lantheus Holdings, Inc.¹⁵

The numbers on this page point here. Each one links to the record it came from.